E.et al (2006)
Individuals who screen positive or have a history of eating disorders should be referred to an obesity medicine specialist and an eating disorders specialist prior to prescribing GLP-1s
The terms used for the literature research were time-restricted feeding, time-restricted eating, intermittent fasting, feeding schedule, food timing, meal frequency, compressed feeding, and restricted food intake. These terms were then united with OR. In addition, the terms normal human, adult, patient, and human were linked with OR. The terms immune, immunity, immunologic, lymphocyte, chemokine, interleukin, C-reactive protein, CRP, neutrophils, oxidative stress, oxidative burst, inflammatory, inflammation, immunoglobulin, autoimmune, lipid peroxidation, homocysteine, malondialdehyde, MDA, glutathione, and GSH were united with OR and then added together with the aforementioned terms
Bioactive plant metabolites in the management of non-communicable metabolic diseases: looking at opportunities beyond the horizon
For the trial-by-trial numbers, see what each GLP-1 medication actually delivers
